Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 19 | 2020 | 1905 | 2.870 |
Why?
|
Nanotechnology | 11 | 2012 | 710 | 1.870 |
Why?
|
Drug Carriers | 8 | 2019 | 693 | 1.700 |
Why?
|
Antineoplastic Agents | 22 | 2019 | 13695 | 1.500 |
Why?
|
Neovascularization, Physiologic | 9 | 2012 | 1351 | 1.420 |
Why?
|
Cisplatin | 8 | 2014 | 1662 | 1.350 |
Why?
|
Nanomedicine | 5 | 2019 | 304 | 1.310 |
Why?
|
Drug Delivery Systems | 11 | 2020 | 2219 | 1.300 |
Why?
|
Neoplasms | 23 | 2021 | 21683 | 1.290 |
Why?
|
Hepatocyte Growth Factor | 6 | 2010 | 270 | 1.230 |
Why?
|
Drug Design | 4 | 2019 | 1076 | 1.110 |
Why?
|
Neovascularization, Pathologic | 8 | 2010 | 2635 | 0.990 |
Why?
|
Nanotubes | 2 | 2021 | 77 | 0.970 |
Why?
|
Cell Communication | 3 | 2021 | 1621 | 0.850 |
Why?
|
Coculture Techniques | 4 | 2020 | 1341 | 0.760 |
Why?
|
Bone Cements | 1 | 2022 | 325 | 0.760 |
Why?
|
Enzyme Inhibitors | 6 | 2019 | 3798 | 0.740 |
Why?
|
Nanocapsules | 2 | 2013 | 91 | 0.730 |
Why?
|
Cell Line, Tumor | 25 | 2021 | 16689 | 0.700 |
Why?
|
Transcytosis | 1 | 2019 | 44 | 0.690 |
Why?
|
Pentose Phosphate Pathway | 1 | 2019 | 124 | 0.680 |
Why?
|
Nanotubes, Carbon | 2 | 2010 | 73 | 0.680 |
Why?
|
Endothelial Cells | 7 | 2020 | 3479 | 0.680 |
Why?
|
Mice, Inbred BALB C | 14 | 2020 | 6386 | 0.670 |
Why?
|
Cytotoxins | 1 | 2019 | 153 | 0.670 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2019 | 207 | 0.630 |
Why?
|
Propionibacterium acnes | 1 | 2018 | 66 | 0.630 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2011 | 282 | 0.620 |
Why?
|
Nanospheres | 2 | 2014 | 20 | 0.600 |
Why?
|
Doxorubicin | 5 | 2010 | 2234 | 0.580 |
Why?
|
Polyethylene Glycols | 3 | 2013 | 1182 | 0.580 |
Why?
|
Neoplasm Proteins | 5 | 2021 | 3703 | 0.560 |
Why?
|
Monitoring, Immunologic | 1 | 2016 | 100 | 0.540 |
Why?
|
Liposomes | 4 | 2016 | 759 | 0.500 |
Why?
|
Carcinoma, Lewis Lung | 3 | 2012 | 114 | 0.490 |
Why?
|
Angiogenesis Inhibitors | 4 | 2005 | 2038 | 0.480 |
Why?
|
Platinum | 2 | 2012 | 233 | 0.460 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2014 | 137 | 0.450 |
Why?
|
Leukocytes | 1 | 2021 | 2043 | 0.450 |
Why?
|
Fullerenes | 2 | 2010 | 14 | 0.450 |
Why?
|
Acne Vulgaris | 1 | 2018 | 302 | 0.450 |
Why?
|
Endothelium, Vascular | 8 | 2021 | 4456 | 0.450 |
Why?
|
Embryonic Stem Cells | 2 | 2012 | 1294 | 0.450 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2012 | 271 | 0.450 |
Why?
|
Mice | 31 | 2024 | 81183 | 0.440 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5172 | 0.440 |
Why?
|
Polymers | 4 | 2016 | 1621 | 0.430 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2013 | 132 | 0.430 |
Why?
|
Animals | 41 | 2024 | 168757 | 0.420 |
Why?
|
Immunoconjugates | 1 | 2019 | 901 | 0.420 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7181 | 0.410 |
Why?
|
Antibodies | 2 | 2019 | 2460 | 0.410 |
Why?
|
Glycomics | 2 | 2011 | 121 | 0.410 |
Why?
|
Cell Survival | 11 | 2021 | 5882 | 0.400 |
Why?
|
Chromones | 2 | 2009 | 154 | 0.390 |
Why?
|
Melanoma, Experimental | 3 | 2009 | 561 | 0.380 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1676 | 0.370 |
Why?
|
Organoplatinum Compounds | 1 | 2012 | 408 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2013 | 2503 | 0.360 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 361 | 0.360 |
Why?
|
Drug Monitoring | 1 | 2016 | 956 | 0.350 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1023 | 0.350 |
Why?
|
Molecular Structure | 4 | 2019 | 1899 | 0.350 |
Why?
|
Heparitin Sulfate | 1 | 2011 | 225 | 0.350 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 730 | 0.350 |
Why?
|
Ticlopidine | 1 | 2014 | 899 | 0.330 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.320 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2727 | 0.310 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.310 |
Why?
|
Anticarcinogenic Agents | 1 | 2009 | 253 | 0.310 |
Why?
|
Morpholines | 2 | 2009 | 571 | 0.310 |
Why?
|
Neoplasms, Experimental | 1 | 2013 | 1276 | 0.300 |
Why?
|
Models, Theoretical | 2 | 2019 | 3589 | 0.300 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 802 | 0.300 |
Why?
|
Leukoplakia | 1 | 2007 | 18 | 0.300 |
Why?
|
Glucose | 1 | 2019 | 4397 | 0.300 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1990 | 0.290 |
Why?
|
Protein Engineering | 3 | 2019 | 540 | 0.280 |
Why?
|
MutS Homolog 2 Protein | 1 | 2007 | 200 | 0.280 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2012 | 3508 | 0.280 |
Why?
|
Breast Neoplasms | 8 | 2021 | 20822 | 0.270 |
Why?
|
Signal Transduction | 11 | 2016 | 23403 | 0.270 |
Why?
|
Neoplasm Metastasis | 5 | 2021 | 4851 | 0.270 |
Why?
|
Medical Oncology | 1 | 2017 | 2265 | 0.260 |
Why?
|
Cholesterol | 3 | 2020 | 2917 | 0.260 |
Why?
|
Molecular Dynamics Simulation | 2 | 2019 | 413 | 0.260 |
Why?
|
Tissue Engineering | 2 | 2015 | 1880 | 0.260 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1741 | 0.260 |
Why?
|
Ginsenosides | 1 | 2004 | 11 | 0.250 |
Why?
|
Fibroblast Growth Factors | 1 | 2011 | 879 | 0.250 |
Why?
|
Panax | 1 | 2004 | 29 | 0.250 |
Why?
|
Permeability | 2 | 2018 | 738 | 0.240 |
Why?
|
Cells, Cultured | 10 | 2018 | 19229 | 0.240 |
Why?
|
MAP Kinase Signaling System | 2 | 2009 | 1526 | 0.240 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 2015 | 0.230 |
Why?
|
Thymidine Phosphorylase | 1 | 2003 | 15 | 0.230 |
Why?
|
Oncogenes | 1 | 2009 | 1265 | 0.230 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.230 |
Why?
|
Models, Molecular | 4 | 2019 | 5456 | 0.220 |
Why?
|
Chitosan | 1 | 2024 | 141 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2019 | 3557 | 0.210 |
Why?
|
Isoenzymes | 2 | 2005 | 1726 | 0.210 |
Why?
|
Phytotherapy | 1 | 2004 | 298 | 0.210 |
Why?
|
Macromolecular Substances | 2 | 2018 | 1454 | 0.210 |
Why?
|
Drug Discovery | 1 | 2010 | 1058 | 0.210 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 371 | 0.200 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3068 | 0.200 |
Why?
|
Immunotherapy | 1 | 2017 | 4445 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 713 | 0.200 |
Why?
|
Polyenes | 2 | 2012 | 69 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1285 | 0.200 |
Why?
|
Humans | 52 | 2024 | 744343 | 0.190 |
Why?
|
Umbilical Veins | 3 | 2009 | 433 | 0.190 |
Why?
|
Peptides | 1 | 2013 | 4409 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5535 | 0.190 |
Why?
|
Inhibitory Concentration 50 | 2 | 2012 | 459 | 0.190 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2013 | 520 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 694 | 0.180 |
Why?
|
DNA Glycosylases | 1 | 2021 | 128 | 0.180 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.180 |
Why?
|
Alginates | 1 | 2021 | 252 | 0.180 |
Why?
|
Lymphokines | 1 | 2003 | 949 | 0.170 |
Why?
|
Chemical Phenomena | 1 | 2019 | 518 | 0.170 |
Why?
|
rho GTP-Binding Proteins | 1 | 2021 | 293 | 0.170 |
Why?
|
Kidney | 2 | 2012 | 7186 | 0.170 |
Why?
|
Drug Stability | 1 | 2019 | 291 | 0.170 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6314 | 0.170 |
Why?
|
Deoxycytidine | 2 | 2013 | 826 | 0.170 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 21827 | 0.160 |
Why?
|
Microtechnology | 1 | 2019 | 70 | 0.160 |
Why?
|
Algorithms | 2 | 2016 | 13881 | 0.160 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 377 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.160 |
Why?
|
Biofilms | 1 | 2022 | 617 | 0.160 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 110 | 0.160 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 193 | 0.150 |
Why?
|
Carrier Proteins | 2 | 2012 | 5021 | 0.150 |
Why?
|
Phenotype | 6 | 2021 | 16365 | 0.150 |
Why?
|
Cytoskeleton | 2 | 2021 | 1185 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 434 | 0.150 |
Why?
|
Models, Biological | 4 | 2016 | 9583 | 0.150 |
Why?
|
Stem Cells | 1 | 2011 | 3567 | 0.150 |
Why?
|
Antibody Specificity | 1 | 2019 | 1095 | 0.150 |
Why?
|
DNA Gyrase | 1 | 2018 | 83 | 0.150 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2214 | 0.140 |
Why?
|
Apoptosis | 6 | 2016 | 9727 | 0.140 |
Why?
|
Phosphorylation | 5 | 2009 | 8436 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2007 | 4034 | 0.140 |
Why?
|
Tissue Distribution | 3 | 2016 | 2327 | 0.140 |
Why?
|
Head and Neck Neoplasms | 3 | 2007 | 2734 | 0.140 |
Why?
|
Esterases | 1 | 2016 | 95 | 0.140 |
Why?
|
Shear Strength | 1 | 2016 | 165 | 0.140 |
Why?
|
Melanoma | 3 | 2009 | 5510 | 0.140 |
Why?
|
Nitric Oxide | 1 | 2005 | 2132 | 0.140 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2020 | 428 | 0.140 |
Why?
|
Administration, Topical | 1 | 2018 | 690 | 0.140 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3586 | 0.130 |
Why?
|
Hydrogels | 1 | 2021 | 724 | 0.130 |
Why?
|
Bibenzyls | 2 | 2005 | 11 | 0.130 |
Why?
|
Substrate Specificity | 1 | 2019 | 1801 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 1012 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 996 | 0.130 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5867 | 0.130 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2013 | 712 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9438 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1387 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2005 | 255 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11524 | 0.120 |
Why?
|
Pyridines | 2 | 2004 | 2825 | 0.120 |
Why?
|
Rats | 3 | 2022 | 24260 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2018 | 63114 | 0.120 |
Why?
|
Stilbenes | 2 | 2005 | 156 | 0.120 |
Why?
|
Zebrafish | 3 | 2010 | 2994 | 0.120 |
Why?
|
Cell Membrane | 2 | 2016 | 3748 | 0.120 |
Why?
|
Membrane Microdomains | 1 | 2015 | 203 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2938 | 0.120 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18029 | 0.120 |
Why?
|
Keratinocytes | 1 | 2018 | 798 | 0.120 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4554 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 1375 | 0.110 |
Why?
|
Flavonoids | 2 | 2009 | 443 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 546 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
Mice, Nude | 1 | 2019 | 3689 | 0.110 |
Why?
|
Tumor Burden | 2 | 2016 | 1915 | 0.110 |
Why?
|
DNA Methylation | 1 | 2007 | 4286 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 2016 | 651 | 0.110 |
Why?
|
Podophyllotoxin | 1 | 2012 | 21 | 0.110 |
Why?
|
Maleates | 1 | 2012 | 17 | 0.110 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1736 | 0.110 |
Why?
|
Receptor, IGF Type 2 | 1 | 2012 | 35 | 0.110 |
Why?
|
Ligands | 1 | 2019 | 3282 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2013 | 640 | 0.100 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 1000 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1423 | 0.100 |
Why?
|
Succinic Acid | 1 | 2012 | 83 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5853 | 0.100 |
Why?
|
Glucosamine | 1 | 2012 | 132 | 0.100 |
Why?
|
Embryoid Bodies | 1 | 2012 | 67 | 0.100 |
Why?
|
Heparan Sulfate Proteoglycans | 2 | 2009 | 118 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2133 | 0.100 |
Why?
|
Taxoids | 1 | 2015 | 666 | 0.100 |
Why?
|
Cell Division | 3 | 2003 | 4568 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1686 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2016 | 739 | 0.100 |
Why?
|
Paclitaxel | 2 | 2016 | 1708 | 0.100 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3129 | 0.100 |
Why?
|
Nanostructures | 1 | 2016 | 551 | 0.100 |
Why?
|
Molecular Weight | 1 | 2013 | 2255 | 0.100 |
Why?
|
Phthalazines | 2 | 2004 | 363 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6364 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.100 |
Why?
|
Cell Line | 2 | 2018 | 15997 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6114 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 849 | 0.090 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2010 | 29 | 0.090 |
Why?
|
Oligopeptides | 1 | 2016 | 1189 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1035 | 0.090 |
Why?
|
Base Sequence | 1 | 2021 | 12797 | 0.090 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2015 | 964 | 0.090 |
Why?
|
Protein Stability | 1 | 2012 | 557 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 626 | 0.090 |
Why?
|
Hydroxides | 1 | 2009 | 47 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2011 | 5974 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 390 | 0.090 |
Why?
|
Cell Differentiation | 3 | 2012 | 11483 | 0.080 |
Why?
|
Endothelium | 1 | 2012 | 778 | 0.080 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 436 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 625 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2934 | 0.080 |
Why?
|
Sulfotransferases | 1 | 2009 | 151 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2015 | 3144 | 0.080 |
Why?
|
Male | 14 | 2018 | 350118 | 0.080 |
Why?
|
Glycocalyx | 1 | 2009 | 88 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2011 | 3617 | 0.080 |
Why?
|
Mesoderm | 1 | 2012 | 686 | 0.080 |
Why?
|
Crystallization | 1 | 2009 | 524 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2699 | 0.080 |
Why?
|
Drug Compounding | 1 | 2009 | 242 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2077 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7913 | 0.080 |
Why?
|
Molecular Conformation | 1 | 2009 | 563 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2596 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1917 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 627 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8301 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3200 | 0.080 |
Why?
|
Female | 12 | 2021 | 380194 | 0.080 |
Why?
|
Solubility | 1 | 2009 | 1085 | 0.080 |
Why?
|
Regenerative Medicine | 1 | 2011 | 307 | 0.070 |
Why?
|
Carboplatin | 1 | 2010 | 801 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3690 | 0.070 |
Why?
|
Transfection | 3 | 2006 | 5892 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1376 | 0.070 |
Why?
|
Surface Properties | 1 | 2009 | 1184 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1583 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2019 | 10481 | 0.070 |
Why?
|
Materials Testing | 1 | 2009 | 867 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2252 | 0.070 |
Why?
|
Nitric Oxide Donors | 1 | 2005 | 121 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2010 | 1117 | 0.060 |
Why?
|
Spleen | 1 | 2011 | 2362 | 0.060 |
Why?
|
Korea | 1 | 2004 | 99 | 0.060 |
Why?
|
Biological Transport | 1 | 2009 | 2118 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.060 |
Why?
|
Americas | 1 | 2004 | 111 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 2557 | 0.060 |
Why?
|
Surgical Sponges | 1 | 2004 | 46 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2007 | 1758 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 985 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2005 | 201 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4364 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6196 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4026 | 0.060 |
Why?
|
Lipoxygenase | 1 | 2003 | 74 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.060 |
Why?
|
Deoxyribose | 1 | 2003 | 6 | 0.060 |
Why?
|
Drug Implants | 1 | 2004 | 244 | 0.060 |
Why?
|
Ribosemonophosphates | 1 | 2003 | 6 | 0.060 |
Why?
|
Cyclooxygenase 1 | 1 | 2003 | 104 | 0.060 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2003 | 94 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2007 | 426 | 0.060 |
Why?
|
Cell Cycle | 2 | 2009 | 2967 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 684 | 0.060 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 276 | 0.060 |
Why?
|
Water | 1 | 2009 | 1395 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10943 | 0.060 |
Why?
|
Models, Animal | 1 | 2009 | 2171 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
Breast | 1 | 2012 | 1969 | 0.050 |
Why?
|
Aneuploidy | 1 | 2006 | 530 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 171 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2004 | 339 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2003 | 624 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1708 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 916 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40075 | 0.050 |
Why?
|
Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
Genomic Instability | 1 | 2006 | 695 | 0.050 |
Why?
|
Aerosols | 1 | 2004 | 625 | 0.050 |
Why?
|
Laminin | 1 | 2003 | 419 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 320 | 0.050 |
Why?
|
Androstadienes | 1 | 2003 | 346 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.050 |
Why?
|
Invertebrates | 1 | 2021 | 50 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 611 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11366 | 0.050 |
Why?
|
Chalcones | 1 | 2020 | 28 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9734 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 648 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2006 | 601 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 2007 | 668 | 0.050 |
Why?
|
Particle Size | 2 | 2021 | 1642 | 0.050 |
Why?
|
Heme Oxygenase-1 | 1 | 2003 | 381 | 0.050 |
Why?
|
Genes, Helminth | 1 | 2021 | 147 | 0.050 |
Why?
|
Kupffer Cells | 1 | 2020 | 142 | 0.050 |
Why?
|
Transcription Initiation Site | 1 | 2021 | 196 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.050 |
Why?
|
Propionates | 1 | 2020 | 169 | 0.050 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 109 | 0.040 |
Why?
|
Species Specificity | 1 | 2004 | 2478 | 0.040 |
Why?
|
Helminth Proteins | 1 | 2021 | 171 | 0.040 |
Why?
|
Biological Assay | 1 | 2003 | 652 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6171 | 0.040 |
Why?
|
Proteoglycans | 1 | 2003 | 835 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.040 |
Why?
|
Genes, Homeobox | 1 | 2021 | 286 | 0.040 |
Why?
|
Vertebrates | 1 | 2021 | 227 | 0.040 |
Why?
|
Macrolides | 1 | 2020 | 201 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 664 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4262 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 890 | 0.040 |
Why?
|
China | 1 | 2004 | 2248 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9386 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13815 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1085 | 0.040 |
Why?
|
Drug Combinations | 1 | 2003 | 1959 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1127 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 18111 | 0.040 |
Why?
|
Heparin | 1 | 2004 | 1637 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2003 | 3701 | 0.040 |
Why?
|
Cytoplasm | 1 | 2021 | 1539 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2003 | 7880 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3507 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2839 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2021 | 2256 | 0.030 |
Why?
|
Lysine | 1 | 2021 | 1007 | 0.030 |
Why?
|
Catalase | 1 | 2016 | 222 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7322 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2011 | 14557 | 0.030 |
Why?
|
Microfluidics | 1 | 2021 | 662 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2187 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6489 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1856 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 5256 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3462 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2689 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1211 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8428 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5917 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1678 | 0.030 |
Why?
|
Blood Platelets | 1 | 2024 | 2508 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6622 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 731 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1940 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1643 | 0.030 |
Why?
|
Hemorrhage | 1 | 2024 | 3461 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2969 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 407 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 976 | 0.020 |
Why?
|
Proteome | 1 | 2021 | 1799 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1706 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1792 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.020 |
Why?
|
Anticoagulants | 1 | 2024 | 4599 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1663 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 1133 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2006 | 52 | 0.020 |
Why?
|
Cyclin B | 1 | 2006 | 108 | 0.020 |
Why?
|
Mitotic Index | 1 | 2006 | 172 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4186 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
Lung | 1 | 2004 | 9856 | 0.020 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 168 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 12072 | 0.020 |
Why?
|
Chromosomal Instability | 1 | 2006 | 184 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7474 | 0.020 |
Why?
|
Absorption | 1 | 2004 | 248 | 0.020 |
Why?
|
Child, Preschool | 1 | 2007 | 41006 | 0.020 |
Why?
|
Biological Availability | 1 | 2004 | 397 | 0.010 |
Why?
|
Immunoblotting | 1 | 2006 | 1682 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 2505 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 57776 | 0.010 |
Why?
|
Emphysema | 1 | 2004 | 247 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1105 | 0.010 |
Why?
|
Mitosis | 1 | 2006 | 1208 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
India | 1 | 2006 | 2197 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
Child | 1 | 2007 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 85781 | 0.010 |
Why?
|
Phagocytosis | 1 | 2003 | 1539 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4894 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 2126 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3920 | 0.010 |
Why?
|
Aged | 1 | 2007 | 163280 | 0.010 |
Why?
|
Middle Aged | 1 | 2007 | 213383 | 0.010 |
Why?
|
Adult | 1 | 2007 | 214055 | 0.010 |
Why?
|
Thrombosis | 1 | 2004 | 2968 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7722 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2003 | 13033 | 0.010 |
Why?
|
Proteins | 1 | 2003 | 6103 | 0.010 |
Why?
|